Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Delforge

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Hospital Infection|June 29, 2020
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staffC Martin, I Montesinos, N Dauby, et al.
Leukemia|June 20, 2017
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromesU Platzbecker, A Symeonidis, E N Oliva, et al.
Pathologie-Biologie|June 9, 2005
[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study]C Focan, F Kreutz, L Longrée, et al.
Annals of Hematology|March 17, 2010
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myelomaA Palumbo, F Davies, M Kropff, et al.
Acta Clinica Belgica|December 8, 2011
Recommended indications for the administration of polyclonal immunoglobulin preparationsM Delforge, C M Farber, P Spath, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple MyelomaP Thilakarathne, A Palumbo, J Diels, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2019
Combining conventional therapy with immunotherapy: A risky business?A Coosemans, A Vankerckhoven, T Baert, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Acta Gastro-Enterologica Belgica|January 1, 1996
Incidence of inflammatory bowel disease in the province of Liège (Belgium). La Société de Gastroentérologie LiègeoiseP Latour, J Belaiche, E Louis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Hospital Infection|June 29, 2020
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staffC Martin, I Montesinos, N Dauby, et al.
Leukemia|June 20, 2017
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromesU Platzbecker, A Symeonidis, E N Oliva, et al.
Pathologie-Biologie|June 9, 2005
[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study]C Focan, F Kreutz, L Longrée, et al.
Annals of Hematology|March 17, 2010
Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myelomaA Palumbo, F Davies, M Kropff, et al.
Acta Clinica Belgica|December 8, 2011
Recommended indications for the administration of polyclonal immunoglobulin preparationsM Delforge, C M Farber, P Spath, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple MyelomaP Thilakarathne, A Palumbo, J Diels, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2019
Combining conventional therapy with immunotherapy: A risky business?A Coosemans, A Vankerckhoven, T Baert, et al.
The Netherlands Journal of Medicine|March 7, 2013
Guideline for diagnosis and treatment of Waldenström's macroglobulinaemiaJ M I Vos, M C Minnema, P W Wijermans, et al.
Acta Gastro-Enterologica Belgica|January 1, 1996
Incidence of inflammatory bowel disease in the province of Liège (Belgium). La Société de Gastroentérologie LiègeoiseP Latour, J Belaiche, E Louis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
Pageof 11